Skip to content

Clinical trials

Terminated Phase 1 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 1 Status: Terminated Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20152
20171
20192
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Alzheimer's Disease Expert Lab (ADEL), Inc.1
Avid Radiopharmaceuticals1
Eli Lilly and Company1
High Point Pharmaceuticals, LLC.1
Michael J. Fox Foundation for Parkinson's Research1
Oregon Health and Science University1
Syndesi Therapeutics1
University of Arizona1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction10
Alzheimer Disease5
Dementia2
Brain Diseases1
Central Nervous System Diseases1
Cognition Disorders1
Mental Disorders1
Movement Disorders1
Nervous System Diseases1
Neurocognitive Disorders1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.